Biotech Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report January 8, 2025
Biotech Xeltis announces completion of enrolment in EU Pivotal Trial for aXess and prepares for market approval January 7, 2025
Biotech Asieris and CDC Sign Investigational Product Supply Agreement for APL-1202 in Free-Living Amoeba Infections Treatment under Expanded Access Investigational New Drug Program January 6, 2025
Biotech Optimizing Outsourcing: A Case Study on Evaluating CDMO Capabilities for API and FD Development January 3, 2025
Biotech Fapon Biopharma Introduces FP008 at Biotech Showcase: A Safer and More Effective Immunotherapy for Refractory Cancers January 2, 2025
Biotech IDEAYA Biosciences Enters Exclusive License with Hengrui Pharma for SHR-4849, a Novel Phase 1 DLL3 Topo-I-Payload ADC Targeting SCLC and NET Solid Tumors December 30, 2024
Biotech Precigen Announces $79.0 Million Private Placement Offering of Convertible Preferred Stock December 29, 2024
Search
Biotech
January 8, 2025
January 7, 2025
January 6, 2025
January 3, 2025
January 2, 2025
January 1, 2025
December 31, 2024
December 30, 2024
December 29, 2024
December 28, 2024
